Protara Therapeutics Inc (TARA)
3.74
+0.03
(+0.81%)
USD |
NASDAQ |
May 16, 16:00
3.71
-0.03
(-0.80%)
After-Hours: 20:00
Protara Therapeutics Shareholders Equity (Quarterly): 58.41M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 58.41M |
| December 31, 2023 | 68.32M |
| September 30, 2023 | 76.96M |
| June 30, 2023 | 85.22M |
| March 31, 2023 | 94.77M |
| December 31, 2022 | 102.08M |
| September 30, 2022 | 139.18M |
| June 30, 2022 | 145.46M |
| March 31, 2022 | 152.24M |
| December 31, 2021 | 161.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 170.41M |
| June 30, 2021 | 178.40M |
| March 31, 2021 | 188.13M |
| December 31, 2020 | 199.24M |
| September 30, 2020 | 194.63M |
| June 30, 2020 | 59.43M |
| March 31, 2020 | 64.74M |
| December 31, 2019 | -2.128M |
| September 30, 2019 | 51.91M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.128M
Minimum
Dec 2019
199.24M
Maximum
Dec 2020
115.23M
Average
102.08M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| AngioDynamics Inc | 218.70M |
| Regulus Therapeutics Inc | 107.59M |
| Bio-Path Holdings Inc | 0.441M |
| Outset Medical Inc | 93.20M |
| AN2 Therapeutics Inc | 110.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.13M |
| Total Liabilities (Quarterly) | 9.728M |